Skip to main content
OpenTrials

Clinical trial condition

Smoldering Multiple Myeloma

Explore clinical trials studying Smoldering Multiple Myeloma. Study availability and eligibility vary by location and protocol.

44 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Smoldering Multiple Myeloma trial results

Completed

Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

NCT01441973

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Sharp Clinical Oncology Research San Diego, California, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Va Connecticut Healthcare System West Haven, Connecticut, United States
  • Winship Cancer Institute. Atlanta, Georgia, United States
View Trial Details
Completed

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

NCT01718899

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions